| Ytd | 18.37% | |
| 1y | -22.67% |
| Open | 1.10 | Prev Close | 1.10 | Low | 1.10 | High | 1.16 | Mkt Cap | 22.35M |
| Vol | 48.26K | Avg Vol | 70.97K | EPS | -0.75 | P/E | N/A | Forward P/E | -1.22 |
| Beta | 1.45 | Short Ratio | 0.12 | Inst. Own | 6.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.02 | 200-d Avg | 1.09 | 1yr Est | 8.00 |
COCP News
BOTHELL, Wash., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) ("Cocrystal"
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.23) per share which missed the analy
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b
Zevra Therapeutics (NASDAQ: ZVRA - Get Free Report) and Cocrystal Pharma (NASDAQ: COCP - Get Free Re
BOTHELL, Wash. , June 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma Inc. (Nasdaq: COCP) ("Cocrystal"
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_06012026_COCP_Bautz.pdf
Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for
Novel, potent pan-viral inhibitors targeting the viral replication complex are under development for
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.17) per share which missed the analy
BOTHELL, Wash., May 15, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal”
Ongoing Phase 1b human challenge study with oral, direct-acting protease inhibitor is designed to de
BOTHELL, Wash., April 30, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal
$150,000,000 Cocrystal Pharma, Inc. Common StockPreferred StockWarrantsUnits Cocrystal Pharma, Inc.
COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after re
US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Q
US stocks traded lower on Thursday, with the Nasdaq falling 1%. Energy shares rose, while consumer d
The company said the FDA's Fast Track designation is intended to facilitate development and expedite
Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track
FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus
FDA Fast Track designation supports accelerated development and expedites regulatory review Noroviru
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.17) per share which beat the analyst
Phase 1b norovirus challenge study is underway at Emory University School of Medicine CDI-988 is the
Cocrystal Pharma (NASDAQ: COCP - Get Free Report) is anticipated to issue its results before the mar
Cocrystal Pharma, Inc. (NASDAQ: COCP - Get Free Report)'s stock price traded up 2% during mid-day tr
CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is
CDI-988 is a direct-acting, oral antiviral being developed for norovirus Norovirus challenge study i
BOTHELL, Wash., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal”
Cocrystal Pharma, Inc. (NASDAQ: COCP - Get Free Report) Director Phillip Md Et Al Frost bought 20,00
BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal”
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal”
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatment Expects to
Investment by Directors and Management demonstrates confidence in the Company Potential for an addit
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursd
On Wednesday, 258 companies hit new 52-week lows.
Tuesday's session saw 325 companies set new 52-week lows.
OnFriday, 143 stocks hit new 52-week lows.
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after